Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells

被引:63
作者
Zhang, J
Hsu, JC
Kinseth, MA
Bjeldanes, LF
Firestone, GL
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA
关键词
indole-3-carbinol; prostate carcinoma cells; cell cycle control; growth inhibition; cyclin-dependent kinase; gene expression; protein kinase activity; prostate-specific antigen;
D O I
10.1002/cncr.11844
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Indole-3-carbinol (13C), a naturally occurring component of Brassica vegetables, such as cabbage, broccoli, and Brussels sprouts, is a promising anticancer agent for certain reproductive tumor cells. The objective of the current study was to characterize the cell cycle effects of 13C in human prostate carcinoma cells. METHODS. The incorporation of [H-3]thymidine and flow cytometry of propidium iodide-stained nuclei were used to monitor 13C-regulated changes in prostate carcinoma cell proliferation and cell cycle progression. Western blotting was used to document expression changes in cell cycle components and prostate-specific antigen (PSA) levels. The enzymatic activities of cyclin-dependent kinases (CDK) were tested by in vitro protein kinase assays using the retinoblastoma protein as a substrate. RESULTS. 13C suppressed the growth of LNCaP prostate carcinoma cells in a dose-dependent manner by inducing a G1 block in cell cycle progression. 13C selectively inhibited the expression of CDK6 protein and transcripts and strongly stimulated the production of the p16 CDK inhibitor. In vitro protein kinase assays revealed the striking inhibition by 13C of immunoprecipitated CDK2 enzymatic activity and the relatively minor down-regulation of CDK4 enzymatic activity. In LNCaP prostate carcinoma cells, 13C treatment inhibited production of PSA, whereas combinations of 13C and the androgen antagonist flutamide more effectively inhibited DNA synthesis and PSA levels compared with either agent alone. CONCLUSIONS. The results of the current study demonstrated that 13C has a potent antiproliferative effect in LNCaP and other human prostate carcinoma cells. These findings implicate this dietary indole as a potential chemotherapeutic agent for controlling the growth of human prostate carcinoma cells. (C) 2003 American Cancer Society.
引用
收藏
页码:2511 / 2520
页数:10
相关论文
共 49 条
[11]  
Costello JF, 1997, CANCER RES, V57, P1250
[12]   Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling [J].
Cover, CM ;
Hsieh, SJ ;
Tran, SH ;
Hallden, G ;
Kim, GS ;
Bjeldanes, LF ;
Firestone, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (07) :3838-3847
[13]  
Cover CM, 1999, CANCER RES, V59, P1244
[14]   Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter [J].
Cram, EJ ;
Liu, BD ;
Bjeldanes, LF ;
Firestone, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) :22332-22340
[15]  
Dictor M, 1999, AM J CLIN PATHOL, V112, pS40
[16]   Transcriptional regulation of the p21(WAF1/ClP1) gene [J].
Gartel, AL ;
Tyner, AL .
EXPERIMENTAL CELL RESEARCH, 1999, 246 (02) :280-289
[17]   FLUTAMIDE - AN ANTIANDROGEN FOR ADVANCED PROSTATE-CANCER [J].
GOLDSPIEL, BR ;
KOHLER, DR .
DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (06) :616-623
[18]   Prognostic markers in localized prostate cancer: From microscopes to molecules [J].
Harding, MA ;
Theodorescu, D .
CANCER AND METASTASIS REVIEWS, 1998, 17 (04) :429-437
[19]   Whole-grain intake and cancer: An expanded review and meta-analysis [J].
Jacobs, DR ;
Marquart, L ;
Slavin, J ;
Kushi, LH .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 30 (02) :85-96
[20]   Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP [J].
Jeon, KI ;
Rih, JK ;
Kim, HJ ;
Lee, YJ ;
Cho, CH ;
Goldberg, ID ;
Rosen, EM ;
Bae, I .
FEBS LETTERS, 2003, 544 (1-3) :246-251